首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備 POC診斷

床旁分子診斷的全球市場規模、份額和行業趨勢分析報告：2023-2030年按產品/服務、最終用戶、技術、應用和地區劃分的展望和預測

市場調查報告書

商品編碼

1309716

床旁分子診斷的全球市場規模、份額和行業趨勢分析報告：2023-2030年按產品/服務、最終用戶、技術、應用和地區劃分的展望和預測

Global Point of Care Molecular Diagnostics Market Size, Share & Industry Trends Analysis Report By Product & Service, By End User, By Technology, By Application, By Regional Outlook and Forecast, 2023 - 2030

出版日期: 2023年06月30日 | 出版商:

KBV Research | 英文 313 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

到 2030 年，即時分子診斷市場規模預計將達到 41 億美元，預測期內復合年增長率為 10.2%。

根據 KBV 基數矩陣中的分析，F. Hoffmann-La Roche Ltd. 是該市場的先驅。 2020 年 6 月，羅氏與 SpeeDx 合作，讓羅氏診斷為臨床醫生提供重要且先進的工具，用於檢測性傳播感染患者的抗生素耐藥性。Danaher Corporation、Thermo Fisher Scientific, Inc.、Abbott Laboratories是該市場的主要創新者。

市場增長因素

老年人口增加

幾乎在每個國家，老年人在人口中的比例都在增加。世界衛生組織估計，到 2030 年，全球六分之一的人將超過 60 歲。至此，60歲及以上的人口將從2020年的10億增加到14億。到 2050 年，60 歲及以上的人口數量將翻一番，達到 21 億。在預測期內，隨著世界人口老齡化和呼吸系統疾病患病率的增加，對即時護理 (POC) 分子診斷的需求將會增加。

去中心化醫療保健系統的普及支持市場擴張

由於準確、高效的治療選擇需要快速診斷結果，床旁檢測對於以患者為中心的醫療保健至關重要。對慢性病、傳染病和慢性病從集中式護理點檢測向分散式檢測的轉變，使患者更容易獲得這些診斷。由於快速檢測的需求，許多公司開發了針對分散設施的傳染病檢測。這些新興市場的發展預計將對全球市場的增長產生積極影響。

市場抑制因素

兌換狀態不足

醫療費用不足是床旁分子診斷市場擴張的障礙。診斷公司遇到的主要困難之一是從醫療保險和私人健康保險公司獲得診斷測試的報銷。 2018 年，美國醫療保險改變了一些體外診斷 (IVD) 測試的報銷方式，例如即時分子檢測。不同的利益團體可以充當有說服力的遊說者，以增加測試的價值並產生適當金額的報銷。預計這些變量將對即時分子檢測市場產生負面影響。

產品和服務展望

根據產品和服務，市場分為檢測和試劑盒、儀器和分析儀以及軟件和服務。到 2022 年，儀器和分析儀領域將在市場中佔據重要的收入份額。使用分子分析儀對血漿、尿液、痰和拭子等樣本進行測試。大多數分子系統提供廣泛的檢測參數，包括結核病、衣原體、HIV-1、HBV 和 HCV。因此，隨著越來越多的人感染結核病、呼吸道疾病等，儀器和分析儀的市場正在擴大。

最終用戶的展望

按最終用戶分為診所、醫院/ICU、研究所等。 2022年，診所業務在市場中佔據最大的收入份額。 POC 分子測試、試劑盒和系統通常在這些情況下使用，因為它們可以在 30 分鐘內快速找到結果。這使得快速診斷成為可能，並允許醫生快速確定和跟蹤患者的病情。

技術展望

按技術劃分，市場分為 RT-PCR、等溫核酸擴增技術 (INAAT) 和其他技術。 INAAT 行業在 2022 年市場中佔據了顯著的收入份額。由於慢性病患病率上升和人口老齡化，預計 INAAT（等溫核酸擴增技術）將會增長。越來越多地採用 INAAT 取代 PCR，以及對負擔得起且高效的診斷程序的需求不斷增長，也是推動該細分市場擴張的主要因素。

應用前景

按應用，市場分為呼吸系統疾病、性傳播疾病、醫院獲得性疾病、肝炎、癌症、胃腸道疾病等。 2022年，呼吸系統疾病領域以最高的收入份額主導市場。傳染病發病率的增加以及對這些疾病的早期診斷和識別的需求不斷增長是推動該細分市場擴張的主要因素。

區域展望

按地區劃分，我們對北美、歐洲、亞太地區和拉美地區 (LAMEA) 的市場進行了分析。 2022年，北美地區以最大的收入份額引領市場。影響市場擴張的主要因素之一是當地醫療系統承受的惡性腫瘤和傳染病的沉重負擔。預計支持該地區 POC 分子診斷市場發展的其他因素包括發達的醫療基礎設施和對先進技術的日益接受。

內容

第 1 章市場範圍與研究方法

市場定義
目的
市場範圍
細分
調查方法

第 2 章市場概述

簡介
- 摘要
  - 市場構成和情況
影響市場的主要因素
- 市場促進因素
- 市場抑制因素

第 3 章競爭分析 - 世界

KBV 基數矩陣
近期全行業戰略發展
- 隸屬關係、協議和協議
- 產品發布和產品擴展
- 收購與合併
關鍵成功策略
- 主要策略

第 4 章全球護理點分子診斷市場：按產品和服務分類

全球檢測和試劑盒市場：按地區
全球儀器和分析設備市場：按地區
全球軟件和服務市場：按地區

第 5 章全球護理點分子診斷市場：按最終用戶劃分

全球醫師辦公室市場：按地區
全球醫院和 ICU 市場：按地區
全球研究院市場：按地區
世界各地的其他市場：按地區

第 6 章全球護理點分子診斷市場：按技術分類

全球 RT-PCR 市場：按地區劃分
全球等溫核酸擴增技術 (INAAT) 市場：按地區
世界各地的其他市場：按地區

第 7 章全球護理點分子診斷市場：按應用分類

全球呼吸系統疾病市場：按地區
全球醫院傳染病市場：按地區
全球性傳播疾病市場：按地區
全球癌症市場：按地區
全球肝炎市場：按地區
全球胃腸病學市場：按地區
世界各地的其他市場：按地區

第 8 章全球護理點分子診斷市場：按地區

北美
- 北美市場：按國家/地區劃分
  - 美國
  - 加拿大
  - 墨西哥
  - 其他北美地區
歐洲
- 歐洲市場：按國家/地區分類
  - 德國
  - 英國
  - 法國
  - 俄羅斯
  - 西班牙
  - 意大利
  - 其他歐洲地區
亞太地區
- 亞太市場：按國家分類
  - 中國
  - 日本
  - 印度
  - 韓國
  - 新加坡
  - 馬來西亞
  - 其他亞太地區
拉丁美洲/中東/非洲
- 按國家/地區劃分的拉丁美洲/中東/非洲市場
  - 巴西
  - 阿根廷
  - 阿拉伯聯合酋長國
  - 沙特阿拉伯
  - 南非
  - 尼日利亞
  - 其他拉丁美洲/中東/非洲地區

第 9 章公司簡介

Abbott Laboratories
Bayer AG
Thermo Fisher Scientific, Inc
F Hoffmann-La Roche Ltd.
BioMerieux SA
Qiagen NV
Danaher Corporation
Bio-Rad laboratories, Inc
Agilent Technologies, Inc
Nova Biomedical Corporation

簡介目錄圖表

The Global Point of Care Molecular Diagnostics Market size is expected to reach $4.1 billion by 2030, rising at a market growth of 10.2% CAGR during the forecast period.

A new generation of POC devices that will change gastrointestinal diagnostic routes has been made possible by recent improvements in analytical methods. Hence, Gastrointestinal Disorders segment accounted for $113.1 million revenue in the market in 2022. About one-third of people in North European and North American populations still have Heliobacter pylori infection, compared to prevalence rates of more than 50% in South and East Europe, South America, and Asia. Immigrants from nations with high H. pylori prevalence continue to have a high prevalence of the stomach virus.

However, the younger generations' lower infection rates imply that the prevalence of H. pylori will continue to fall over the next several decades. The most significant risk factors for H. pylori infection are low socioeconomic situations throughout childhood. A hectic schedule is bringing on gastric ailments, an increase in the style of life, and poor eating habits. In 2018, there were reportedly 4.8 million new cases of cancer and 3.4 million deaths from it, according to the WHO, making up 26% of the burden of cancer incidence globally and 35% of all cancer-related fatalities. As a result, the prevalence of stomach illnesses would spur market expansion throughout the forecasted decade.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In March, 2023, QIAGEN N.V. formed a partnership with Servier to develop and validate a real-time in vitro PCR test that can be used to detect IDH1 gene mutations in AML patients in whole blood and bone marrow aspirates. Additionally, In February, 2021, Agilent Technologies formed a partnership with Mammoth Biosciences to offer a simple workflow to address the specific needs of high-throughput clinical testing laboratories.

Based on the Analysis presented in the KBV Cardinal matrix; F. Hoffmann-La Roche Ltd. is the forerunner in the Market. In June, 2020, Roche formed a partnership with SpeeDx to enable Roche Diagnostics to offer clinicians critical and advanced tools for the detection of antibiotic resistance in patients with sexually transmitted infections. Companies such as Danaher Corporation, Thermo Fisher Scientific, Inc., Abbott Laboratories are some of the key innovators in the Market.

Market Growth Factors

An increasing number of older people

In practically every country, the percentage of older adults in the population is growing. WHO estimates that by 2030, 1 in 6 individuals worldwide will be 60 or older. By this point, there will be 1.4 billion people over 60, up from 1 billion in 2020. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Over the projection period, there will be an increase in demand for point-of-care molecular diagnostics due to the increased prevalence of respiratory illnesses and disorders among the aging population globally.

Decentralized Healthcare System Proliferation to Support Market Expansion

Due to the fast diagnostic outcomes necessary for precise and efficient treatment choices, point-of-care testing has become essential for patient-centric healthcare. Patients now have easy access to these diagnostics due to a change from centralized point-of-care testing to decentralized testing for chronic, infectious, and chronic conditions. Many players have created infectious disease tests for dispersed sites due to the demand for quick turnaround testing. These developments will favorably impact the growth of the worldwide market.

Market Restraining Factors

Poor reimbursement circumstances

Inadequate reimbursements are a barrier to the point-of-care molecular diagnostics market's expansion. Among the major difficulties diagnostic firms encounter is receiving reimbursement for diagnostic tests from Medicare and commercial health insurers. In 2018, Medicare in the US changed how some in vitro diagnostic (IVD) tests, such as point-of-care molecular assays, were reimbursed. Diverse interest groups could increase a test's worth and serve as a persuasive lobby to generate reimbursement at the right amount. On the market for point-of-care molecular testing, these variables are projected to have a negative effect.

Product and Services Outlook

Based on product & service, the market is segmented into assays & kits, instruments & analyzers, and software & service. In 2022, the instruments & analyzers segment gained a sizable revenue share in the market. Plasma, urine, sputum, and swab samples are tested using molecular analyzers. Most molecular systems provide a broad range of test parameters, including those for TB, Chlamydia, HIV-1, HBV, and HCV. As a result, the equipment and analyzers market is expanding as more people get TBL, respiratory disorders, etc.

End-user Outlook

By end-user, the market is categorized into physicians' offices, hospitals & ICUs, research institutes, and others. In 2022, the physicians' offices segment registered the largest revenue share in market. Due to its ability to provide quick findings within 30 minutes, POC molecular test & kits and systems are often used in these circumstances. This facilitates prompt diagnosis and enables doctors to determine or track a patient's status quickly.

Technology Outlook

By technology, the market is divided into RT-PCR, Isothermal Nucleic Acid Amplification Technology (INAAT), and other technologies. The INAAT segment recorded a remarkable revenue share in the market in 2022. As a result of the rising prevalence of chronic diseases and an aging population, INAAT (Isothermal Nucleic Acid Amplification Technology) is projected to grow. An increase in the adoption of INAAT over PCR and a rise in demand for affordable and efficient diagnostic procedures are other key factors fueling the segment's expansion.

Application Outlook

On the basis of application, the market is bifurcated into respiratory diseases, sexually transmitted diseases, hospital acquired infections, hepatitis, cancer, gastrointestinal disorders, and others. In 2022, the respiratory diseases segment dominated the market by generating the highest revenue share. The increasing frequency of infectious illnesses and the rising need for early diagnosis and identification of these diseases are the main factors fueling the expansion of this market segment.

Regional Outlook

Region wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market with the maximum revenue share. One of the main factors influencing market expansion is the heavy load of malignancies and infectious illnesses on local healthcare systems. Other factors projected to boost the development of the point-of-care molecular diagnostics market in the area include the existence of a well-developed healthcare infrastructure and the rising acceptance of sophisticated technologies.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd., Qiagen N.V., Danaher Corporation, Bio-Rad Laboratories, Inc., BioMerieux S.A., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and Nova Biomedical Corporation

Recent Strategies Deployed in Point of Care Molecular Diagnostics Market

Partnerships, Collaboration and Agreements:

Mar-2023: QIAGEN N.V. formed a partnership with Servier, a global pharmaceutical group. The partnership aimed to develop and validate a real-time in vitro PCR test that can be used to detect IDH1 gene mutations in AML patients in whole blood and bone marrow aspirates.

Apr-2023: BioMerieux S.A. partnered with Oxford Nanopore Technologies plc, a developer and seller of nanopore sequencing products for the direct, electronic analysis of single molecules. The partnership aimed to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.

Jan-2023: QIAGEN entered into a partnership with Helix, a California-based population genomics leader. Through this partnership, the company would leverage the Helix Laboratory Platform to offer innovative solutions for biopharmaceutical customers.

Feb-2021: Agilent Technologies formed a partnership with Mammoth Biosciences, a private biotechnology company. Through this partnership, the company aimed to offer a simple workflow to address the specific needs of high-throughput clinical testing laboratories.

Product Launch and Product Expansions:

Oct-2022: Roche revealed SARS-CoV-2 Rapid Antibody Test 2.0 for healthcare professionals to identify patients who have developed antibodies against the virus, indicating previous infection or vaccination.

Nov-2021: Roche unveiled cobas 5800 System, a new molecular laboratory instrument. The new system addresses challenges faced by laboratories from the increase in patient testing, reimbursement complexities, and the need for a more diverse testing menu while providing meaningful and timely results.

Acquisitions and Merger:

Aug-2022: Bio-Rad acquired Curiosity Diagnostics, a late-stage, pre-commercial platform company. This acquisition aimed at working closely to bring the latest generation of rapid PCR systems to market. Curiosity's PCR platform, PCR|ONE would offer a streamlined workflow as well as rapid turnaround times and is predicted to extend its reach beyond high-complexity labs into near-patient molecular diagnostics labs.

May-2022: BioMerieux completed the acquisition of Specific Diagnostics, a medical device startup that has developed in vitro diagnostic systems. The acquisition would enable the company to further develop its leadership in clinical microbiology and strengthen its fight against Antimicrobial Resistance.

May-2021: Roche took over GenMark Diagnostics, a leading vendor of multiplex molecular diagnostic solutions. This acquisition aimed to expand Roche's molecular diagnostics offerings to incorporate solutions with the capability to offer lifesaving information to patients, as well as their healthcare providers, rapidly.

Feb-2021: Thermo Fisher Scientific acquired Mesa Biotech, a healthcare test, and data company. The acquisition aimed at rapidly scaling manufacturing volume, driving cost efficiencies as well as bringing much-needed diagnostics to the market faster and at an expanded scale.

Scope of the Study

Market Segments covered in the Report:

By Product & Service

Assays & Kits
Instruments & Analyzers
Software & Services Surveillance & Monitoring

By End User

Physicians Offices
Hospitals & ICUs
Research Institutes
Others

By Technology

RT-PCR
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others

By Application

Respiratory Diseases
Hospital-acquired Infections
Sexually Transmitted Diseases
Cancer
Hepatitis
Gastrointestinal Disorders
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Abbott Laboratories
Bayer AG
F. Hoffmann-La Roche Ltd.
Qiagen N.V.
Danaher Corporation
Bio-Rad Laboratories, Inc.
BioMerieux S.A.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Nova Biomedical Corporation

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Point of Care Molecular Diagnostics Market, by Product & Service
- 1.4.2 Global Point of Care Molecular Diagnostics Market, by End User
- 1.4.3 Global Point of Care Molecular Diagnostics Market, by Technology
- 1.4.4 Global Point of Care Molecular Diagnostics Market, by Application
- 1.4.5 Global Point of Care Molecular Diagnostics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Global Point of Care Molecular Diagnostics Market by Product & Service

4.1 Global Assays & Kits Market by Region
4.2 Global Instruments & Analyzers Market by Region
4.3 Global Software & Services Market by Region

Chapter 5. Global Point of Care Molecular Diagnostics Market by End User

5.1 Global Physicians Offices Market by Region
5.2 Global Hospitals & ICUs Market by Region
5.3 Global Research Institutes Market by Region
5.4 Global Others Market by Region

Chapter 6. Global Point of Care Molecular Diagnostics Market by Technology

6.1 Global RT-PCR Market by Region
6.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Region
6.3 Global Others Market by Region

Chapter 7. Global Point of Care Molecular Diagnostics Market by Application

7.1 Global Respiratory Diseases Market by Region
7.2 Global Hospital-acquired Infections Market by Region
7.3 Global Sexually Transmitted Diseases Market by Region
7.4 Global Cancer Market by Region
7.5 Global Hepatitis Market by Region
7.6 Global Gastrointestinal Disorders Market by Region
7.7 Global Others Market by Region

Chapter 8. Global Point of Care Molecular Diagnostics Market by Region

8.1 North America Point of Care Molecular Diagnostics Market
- 8.1.1 North America Point of Care Molecular Diagnostics Market by Product & Service
  - 8.1.1.1 North America Assays & Kits Market by Country
  - 8.1.1.2 North America Instruments & Analyzers Market by Country
  - 8.1.1.3 North America Software & Services Market by Country
- 8.1.2 North America Point of Care Molecular Diagnostics Market by End User
  - 8.1.2.1 North America Physicians Offices Market by Country
  - 8.1.2.2 North America Hospitals & ICUs Market by Country
  - 8.1.2.3 North America Research Institutes Market by Country
  - 8.1.2.4 North America Others Market by Country
- 8.1.3 North America Point of Care Molecular Diagnostics Market by Technology
  - 8.1.3.1 North America RT-PCR Market by Country
  - 8.1.3.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
  - 8.1.3.3 North America Others Market by Country
- 8.1.4 North America Point of Care Molecular Diagnostics Market by Application
  - 8.1.4.1 North America Respiratory Diseases Market by Country
  - 8.1.4.2 North America Hospital-acquired Infections Market by Country
  - 8.1.4.3 North America Sexually Transmitted Diseases Market by Country
  - 8.1.4.4 North America Cancer Market by Country
  - 8.1.4.5 North America Hepatitis Market by Country
  - 8.1.4.6 North America Gastrointestinal Disorders Market by Country
  - 8.1.4.7 North America Others Market by Country
- 8.1.5 North America Point of Care Molecular Diagnostics Market by Country
  - 8.1.5.1 US Point of Care Molecular Diagnostics Market
    - 8.1.5.1.1 US Point of Care Molecular Diagnostics Market by Product & Service
    - 8.1.5.1.2 US Point of Care Molecular Diagnostics Market by End User
    - 8.1.5.1.3 US Point of Care Molecular Diagnostics Market by Technology
    - 8.1.5.1.4 US Point of Care Molecular Diagnostics Market by Application
  - 8.1.5.2 Canada Point of Care Molecular Diagnostics Market
    - 8.1.5.2.1 Canada Point of Care Molecular Diagnostics Market by Product & Service
    - 8.1.5.2.2 Canada Point of Care Molecular Diagnostics Market by End User
    - 8.1.5.2.3 Canada Point of Care Molecular Diagnostics Market by Technology
    - 8.1.5.2.4 Canada Point of Care Molecular Diagnostics Market by Application
  - 8.1.5.3 Mexico Point of Care Molecular Diagnostics Market
    - 8.1.5.3.1 Mexico Point of Care Molecular Diagnostics Market by Product & Service
    - 8.1.5.3.2 Mexico Point of Care Molecular Diagnostics Market by End User
    - 8.1.5.3.3 Mexico Point of Care Molecular Diagnostics Market by Technology
    - 8.1.5.3.4 Mexico Point of Care Molecular Diagnostics Market by Application
  - 8.1.5.4 Rest of North America Point of Care Molecular Diagnostics Market
    - 8.1.5.4.1 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service
    - 8.1.5.4.2 Rest of North America Point of Care Molecular Diagnostics Market by End User
    - 8.1.5.4.3 Rest of North America Point of Care Molecular Diagnostics Market by Technology
    - 8.1.5.4.4 Rest of North America Point of Care Molecular Diagnostics Market by Application
8.2 Europe Point of Care Molecular Diagnostics Market
- 8.2.1 Europe Point of Care Molecular Diagnostics Market by Product & Service
  - 8.2.1.1 Europe Assays & Kits Market by Country
  - 8.2.1.2 Europe Instruments & Analyzers Market by Country
  - 8.2.1.3 Europe Software & Services Market by Country
- 8.2.2 Europe Point of Care Molecular Diagnostics Market by End User
  - 8.2.2.1 Europe Physicians Offices Market by Country
  - 8.2.2.2 Europe Hospitals & ICUs Market by Country
  - 8.2.2.3 Europe Research Institutes Market by Country
  - 8.2.2.4 Europe Others Market by Country
- 8.2.3 Europe Point of Care Molecular Diagnostics Market by Technology
  - 8.2.3.1 Europe RT-PCR Market by Country
  - 8.2.3.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
  - 8.2.3.3 Europe Others Market by Country
- 8.2.4 Europe Point of Care Molecular Diagnostics Market by Application
  - 8.2.4.1 Europe Respiratory Diseases Market by Country
  - 8.2.4.2 Europe Hospital-acquired Infections Market by Country
  - 8.2.4.3 Europe Sexually Transmitted Diseases Market by Country
  - 8.2.4.4 Europe Cancer Market by Country
  - 8.2.4.5 Europe Hepatitis Market by Country
  - 8.2.4.6 Europe Gastrointestinal Disorders Market by Country
  - 8.2.4.7 Europe Others Market by Country
- 8.2.5 Europe Point of Care Molecular Diagnostics Market by Country
  - 8.2.5.1 Germany Point of Care Molecular Diagnostics Market
    - 8.2.5.1.1 Germany Point of Care Molecular Diagnostics Market by Product & Service
    - 8.2.5.1.2 Germany Point of Care Molecular Diagnostics Market by End User
    - 8.2.5.1.3 Germany Point of Care Molecular Diagnostics Market by Technology
    - 8.2.5.1.4 Germany Point of Care Molecular Diagnostics Market by Application
  - 8.2.5.2 UK Point of Care Molecular Diagnostics Market
    - 8.2.5.2.1 UK Point of Care Molecular Diagnostics Market by Product & Service
    - 8.2.5.2.2 UK Point of Care Molecular Diagnostics Market by End User
    - 8.2.5.2.3 UK Point of Care Molecular Diagnostics Market by Technology
    - 8.2.5.2.4 UK Point of Care Molecular Diagnostics Market by Application
  - 8.2.5.3 France Point of Care Molecular Diagnostics Market
    - 8.2.5.3.1 France Point of Care Molecular Diagnostics Market by Product & Service
    - 8.2.5.3.2 France Point of Care Molecular Diagnostics Market by End User
    - 8.2.5.3.3 France Point of Care Molecular Diagnostics Market by Technology
    - 8.2.5.3.4 France Point of Care Molecular Diagnostics Market by Application
  - 8.2.5.4 Russia Point of Care Molecular Diagnostics Market
    - 8.2.5.4.1 Russia Point of Care Molecular Diagnostics Market by Product & Service
    - 8.2.5.4.2 Russia Point of Care Molecular Diagnostics Market by End User
    - 8.2.5.4.3 Russia Point of Care Molecular Diagnostics Market by Technology
    - 8.2.5.4.4 Russia Point of Care Molecular Diagnostics Market by Application
  - 8.2.5.5 Spain Point of Care Molecular Diagnostics Market
    - 8.2.5.5.1 Spain Point of Care Molecular Diagnostics Market by Product & Service
    - 8.2.5.5.2 Spain Point of Care Molecular Diagnostics Market by End User
    - 8.2.5.5.3 Spain Point of Care Molecular Diagnostics Market by Technology
    - 8.2.5.5.4 Spain Point of Care Molecular Diagnostics Market by Application
  - 8.2.5.6 Italy Point of Care Molecular Diagnostics Market
    - 8.2.5.6.1 Italy Point of Care Molecular Diagnostics Market by Product & Service
    - 8.2.5.6.2 Italy Point of Care Molecular Diagnostics Market by End User
    - 8.2.5.6.3 Italy Point of Care Molecular Diagnostics Market by Technology
    - 8.2.5.6.4 Italy Point of Care Molecular Diagnostics Market by Application
  - 8.2.5.7 Rest of Europe Point of Care Molecular Diagnostics Market
    - 8.2.5.7.1 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service
    - 8.2.5.7.2 Rest of Europe Point of Care Molecular Diagnostics Market by End User
    - 8.2.5.7.3 Rest of Europe Point of Care Molecular Diagnostics Market by Technology
    - 8.2.5.7.4 Rest of Europe Point of Care Molecular Diagnostics Market by Application
8.3 Asia Pacific Point of Care Molecular Diagnostics Market
- 8.3.1 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service
  - 8.3.1.1 Asia Pacific Assays & Kits Market by Country
  - 8.3.1.2 Asia Pacific Instruments & Analyzers Market by Country
  - 8.3.1.3 Asia Pacific Software & Services Market by Country
- 8.3.2 Asia Pacific Point of Care Molecular Diagnostics Market by End User
  - 8.3.2.1 Asia Pacific Physicians Offices Market by Country
  - 8.3.2.2 Asia Pacific Hospitals & ICUs Market by Country
  - 8.3.2.3 Asia Pacific Research Institutes Market by Country
  - 8.3.2.4 Asia Pacific Others Market by Country
- 8.3.3 Asia Pacific Point of Care Molecular Diagnostics Market by Technology
  - 8.3.3.1 Asia Pacific RT-PCR Market by Country
  - 8.3.3.2 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
  - 8.3.3.3 Asia Pacific Others Market by Country
- 8.3.4 Asia Pacific Point of Care Molecular Diagnostics Market by Application
  - 8.3.4.1 Asia Pacific Respiratory Diseases Market by Country
  - 8.3.4.2 Asia Pacific Hospital-acquired Infections Market by Country
  - 8.3.4.3 Asia Pacific Sexually Transmitted Diseases Market by Country
  - 8.3.4.4 Asia Pacific Cancer Market by Country
  - 8.3.4.5 Asia Pacific Hepatitis Market by Country
  - 8.3.4.6 Asia Pacific Gastrointestinal Disorders Market by Country
  - 8.3.4.7 Asia Pacific Others Market by Country
- 8.3.5 Asia Pacific Point of Care Molecular Diagnostics Market by Country
  - 8.3.5.1 China Point of Care Molecular Diagnostics Market
    - 8.3.5.1.1 China Point of Care Molecular Diagnostics Market by Product & Service
    - 8.3.5.1.2 China Point of Care Molecular Diagnostics Market by End User
    - 8.3.5.1.3 China Point of Care Molecular Diagnostics Market by Technology
    - 8.3.5.1.4 China Point of Care Molecular Diagnostics Market by Application
  - 8.3.5.2 Japan Point of Care Molecular Diagnostics Market
    - 8.3.5.2.1 Japan Point of Care Molecular Diagnostics Market by Product & Service
    - 8.3.5.2.2 Japan Point of Care Molecular Diagnostics Market by End User
    - 8.3.5.2.3 Japan Point of Care Molecular Diagnostics Market by Technology
    - 8.3.5.2.4 Japan Point of Care Molecular Diagnostics Market by Application
  - 8.3.5.3 India Point of Care Molecular Diagnostics Market
    - 8.3.5.3.1 India Point of Care Molecular Diagnostics Market by Product & Service
    - 8.3.5.3.2 India Point of Care Molecular Diagnostics Market by End User
    - 8.3.5.3.3 India Point of Care Molecular Diagnostics Market by Technology
    - 8.3.5.3.4 India Point of Care Molecular Diagnostics Market by Application
  - 8.3.5.4 South Korea Point of Care Molecular Diagnostics Market
    - 8.3.5.4.1 South Korea Point of Care Molecular Diagnostics Market by Product & Service
    - 8.3.5.4.2 South Korea Point of Care Molecular Diagnostics Market by End User
    - 8.3.5.4.3 South Korea Point of Care Molecular Diagnostics Market by Technology
    - 8.3.5.4.4 South Korea Point of Care Molecular Diagnostics Market by Application
  - 8.3.5.5 Singapore Point of Care Molecular Diagnostics Market
    - 8.3.5.5.1 Singapore Point of Care Molecular Diagnostics Market by Product & Service
    - 8.3.5.5.2 Singapore Point of Care Molecular Diagnostics Market by End User
    - 8.3.5.5.3 Singapore Point of Care Molecular Diagnostics Market by Technology
    - 8.3.5.5.4 Singapore Point of Care Molecular Diagnostics Market by Application
  - 8.3.5.6 Malaysia Point of Care Molecular Diagnostics Market
    - 8.3.5.6.1 Malaysia Point of Care Molecular Diagnostics Market by Product & Service
    - 8.3.5.6.2 Malaysia Point of Care Molecular Diagnostics Market by End User
    - 8.3.5.6.3 Malaysia Point of Care Molecular Diagnostics Market by Technology
    - 8.3.5.6.4 Malaysia Point of Care Molecular Diagnostics Market by Application
  - 8.3.5.7 Rest of Asia Pacific Point of Care Molecular Diagnostics Market
    - 8.3.5.7.1 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service
    - 8.3.5.7.2 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User
    - 8.3.5.7.3 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology
    - 8.3.5.7.4 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application
8.4 LAMEA Point of Care Molecular Diagnostics Market
- 8.4.1 LAMEA Point of Care Molecular Diagnostics Market by Product & Service
  - 8.4.1.1 LAMEA Assays & Kits Market by Country
  - 8.4.1.2 LAMEA Instruments & Analyzers Market by Country
  - 8.4.1.3 LAMEA Software & Services Market by Country
- 8.4.2 LAMEA Point of Care Molecular Diagnostics Market by End User
  - 8.4.2.1 LAMEA Physicians Offices Market by Country
  - 8.4.2.2 LAMEA Hospitals & ICUs Market by Country
  - 8.4.2.3 LAMEA Research Institutes Market by Country
  - 8.4.2.4 LAMEA Others Market by Country
- 8.4.3 LAMEA Point of Care Molecular Diagnostics Market by Technology
  - 8.4.3.1 LAMEA RT-PCR Market by Country
  - 8.4.3.2 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
  - 8.4.3.3 LAMEA Others Market by Country
- 8.4.4 LAMEA Point of Care Molecular Diagnostics Market by Application
  - 8.4.4.1 LAMEA Respiratory Diseases Market by Country
  - 8.4.4.2 LAMEA Hospital-acquired Infections Market by Country
  - 8.4.4.3 LAMEA Sexually Transmitted Diseases Market by Country
  - 8.4.4.4 LAMEA Cancer Market by Country
  - 8.4.4.5 LAMEA Hepatitis Market by Country
  - 8.4.4.6 LAMEA Gastrointestinal Disorders Market by Country
  - 8.4.4.7 LAMEA Others Market by Country
- 8.4.5 LAMEA Point of Care Molecular Diagnostics Market by Country
  - 8.4.5.1 Brazil Point of Care Molecular Diagnostics Market
    - 8.4.5.1.1 Brazil Point of Care Molecular Diagnostics Market by Product & Service
    - 8.4.5.1.2 Brazil Point of Care Molecular Diagnostics Market by End User
    - 8.4.5.1.3 Brazil Point of Care Molecular Diagnostics Market by Technology
    - 8.4.5.1.4 Brazil Point of Care Molecular Diagnostics Market by Application
  - 8.4.5.2 Argentina Point of Care Molecular Diagnostics Market
    - 8.4.5.2.1 Argentina Point of Care Molecular Diagnostics Market by Product & Service
    - 8.4.5.2.2 Argentina Point of Care Molecular Diagnostics Market by End User
    - 8.4.5.2.3 Argentina Point of Care Molecular Diagnostics Market by Technology
    - 8.4.5.2.4 Argentina Point of Care Molecular Diagnostics Market by Application
  - 8.4.5.3 UAE Point of Care Molecular Diagnostics Market
    - 8.4.5.3.1 UAE Point of Care Molecular Diagnostics Market by Product & Service
    - 8.4.5.3.2 UAE Point of Care Molecular Diagnostics Market by End User
    - 8.4.5.3.3 UAE Point of Care Molecular Diagnostics Market by Technology
    - 8.4.5.3.4 UAE Point of Care Molecular Diagnostics Market by Application
  - 8.4.5.4 Saudi Arabia Point of Care Molecular Diagnostics Market
    - 8.4.5.4.1 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service
    - 8.4.5.4.2 Saudi Arabia Point of Care Molecular Diagnostics Market by End User
    - 8.4.5.4.3 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology
    - 8.4.5.4.4 Saudi Arabia Point of Care Molecular Diagnostics Market by Application
  - 8.4.5.5 South Africa Point of Care Molecular Diagnostics Market
    - 8.4.5.5.1 South Africa Point of Care Molecular Diagnostics Market by Product & Service
    - 8.4.5.5.2 South Africa Point of Care Molecular Diagnostics Market by End User
    - 8.4.5.5.3 South Africa Point of Care Molecular Diagnostics Market by Technology
    - 8.4.5.5.4 South Africa Point of Care Molecular Diagnostics Market by Application
  - 8.4.5.6 Nigeria Point of Care Molecular Diagnostics Market
    - 8.4.5.6.1 Nigeria Point of Care Molecular Diagnostics Market by Product & Service
    - 8.4.5.6.2 Nigeria Point of Care Molecular Diagnostics Market by End User
    - 8.4.5.6.3 Nigeria Point of Care Molecular Diagnostics Market by Technology
    - 8.4.5.6.4 Nigeria Point of Care Molecular Diagnostics Market by Application
  - 8.4.5.7 Rest of LAMEA Point of Care Molecular Diagnostics Market
    - 8.4.5.7.1 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service
    - 8.4.5.7.2 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User
    - 8.4.5.7.3 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology
    - 8.4.5.7.4 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application

Chapter 9. Company Profiles

9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 SWOT Analysis
9.2 Bayer AG
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Acquisition and Mergers:
- 9.3.6 SWOT Analysis
9.4 F. Hoffmann-La Roche Ltd.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
  - 9.4.5.1 Partnerships, Collaborations, and Agreements:
  - 9.4.5.2 Product Launches and Product Expansions:
  - 9.4.5.3 Acquisition and Mergers:
9.5 BioMerieux S.A.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
  - 9.5.5.1 Partnerships, Collaborations, and Agreements:
  - 9.5.5.2 Acquisition and Mergers:
9.6 Qiagen N.V.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Danaher Corporation
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
9.8 Bio-Rad laboratories, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
  - 9.8.5.1 Acquisition and Mergers:
9.9 Agilent Technologies, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
  - 9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Nova Biomedical Corporation
- 9.10.1 Company Overview

簡介目錄圖表

LIST OF TABLES

TABLE 1 Global Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 2 Global Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Point of Care Molecular Diagnostics Market
TABLE 4 Product Launches And Product Expansions- Point of Care Molecular Diagnostics Market
TABLE 5 Acquisition and Mergers- Point of Care Molecular Diagnostics Market
TABLE 6 Global Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 7 Global Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 8 Global Assays & Kits Market by Region, 2019 - 2022, USD Million
TABLE 9 Global Assays & Kits Market by Region, 2023 - 2030, USD Million
TABLE 10 Global Instruments & Analyzers Market by Region, 2019 - 2022, USD Million
TABLE 11 Global Instruments & Analyzers Market by Region, 2023 - 2030, USD Million
TABLE 12 Global Software & Services Market by Region, 2019 - 2022, USD Million
TABLE 13 Global Software & Services Market by Region, 2023 - 2030, USD Million
TABLE 14 Global Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 15 Global Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 16 Global Physicians Offices Market by Region, 2019 - 2022, USD Million
TABLE 17 Global Physicians Offices Market by Region, 2023 - 2030, USD Million
TABLE 18 Global Hospitals & ICUs Market by Region, 2019 - 2022, USD Million
TABLE 19 Global Hospitals & ICUs Market by Region, 2023 - 2030, USD Million
TABLE 20 Global Research Institutes Market by Region, 2019 - 2022, USD Million
TABLE 21 Global Research Institutes Market by Region, 2023 - 2030, USD Million
TABLE 22 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 23 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 24 Global Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 25 Global Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 26 Global RT-PCR Market by Region, 2019 - 2022, USD Million
TABLE 27 Global RT-PCR Market by Region, 2023 - 2030, USD Million
TABLE 28 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Region, 2019 - 2022, USD Million
TABLE 29 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Region, 2023 - 2030, USD Million
TABLE 30 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 31 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 32 Global Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 33 Global Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 34 Global Respiratory Diseases Market by Region, 2019 - 2022, USD Million
TABLE 35 Global Respiratory Diseases Market by Region, 2023 - 2030, USD Million
TABLE 36 Global Hospital-acquired Infections Market by Region, 2019 - 2022, USD Million
TABLE 37 Global Hospital-acquired Infections Market by Region, 2023 - 2030, USD Million
TABLE 38 Global Sexually Transmitted Diseases Market by Region, 2019 - 2022, USD Million
TABLE 39 Global Sexually Transmitted Diseases Market by Region, 2023 - 2030, USD Million
TABLE 40 Global Cancer Market by Region, 2019 - 2022, USD Million
TABLE 41 Global Cancer Market by Region, 2023 - 2030, USD Million
TABLE 42 Global Hepatitis Market by Region, 2019 - 2022, USD Million
TABLE 43 Global Hepatitis Market by Region, 2023 - 2030, USD Million
TABLE 44 Global Gastrointestinal Disorders Market by Region, 2019 - 2022, USD Million
TABLE 45 Global Gastrointestinal Disorders Market by Region, 2023 - 2030, USD Million
TABLE 46 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 47 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 48 Global Point of Care Molecular Diagnostics Market by Region, 2019 - 2022, USD Million
TABLE 49 Global Point of Care Molecular Diagnostics Market by Region, 2023 - 2030, USD Million
TABLE 50 North America Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 51 North America Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 52 North America Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 53 North America Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 54 North America Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 55 North America Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 56 North America Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 57 North America Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 58 North America Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 59 North America Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 60 North America Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 61 North America Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 62 North America Physicians Offices Market by Country, 2019 - 2022, USD Million
TABLE 63 North America Physicians Offices Market by Country, 2023 - 2030, USD Million
TABLE 64 North America Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
TABLE 65 North America Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
TABLE 66 North America Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 67 North America Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 68 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 69 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 70 North America Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 71 North America Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 72 North America RT-PCR Market by Country, 2019 - 2022, USD Million
TABLE 73 North America RT-PCR Market by Country, 2023 - 2030, USD Million
TABLE 74 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
TABLE 75 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
TABLE 76 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 77 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 78 North America Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 79 North America Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 80 North America Respiratory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 81 North America Respiratory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 82 North America Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
TABLE 83 North America Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
TABLE 84 North America Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
TABLE 85 North America Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
TABLE 86 North America Cancer Market by Country, 2019 - 2022, USD Million
TABLE 87 North America Cancer Market by Country, 2023 - 2030, USD Million
TABLE 88 North America Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 89 North America Hepatitis Market by Country, 2023 - 2030, USD Million
TABLE 90 North America Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
TABLE 91 North America Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
TABLE 92 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 93 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 94 North America Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 95 North America Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 96 US Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 97 US Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 98 US Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 99 US Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 100 US Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 101 US Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 102 US Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 103 US Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 104 US Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 105 US Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 106 Canada Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 107 Canada Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 108 Canada Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 109 Canada Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 110 Canada Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 111 Canada Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 112 Canada Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 113 Canada Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 114 Canada Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 115 Canada Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 116 Mexico Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 117 Mexico Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 118 Mexico Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 119 Mexico Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 120 Mexico Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 121 Mexico Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 122 Mexico Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 123 Mexico Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 124 Mexico Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 125 Mexico Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 126 Rest of North America Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 127 Rest of North America Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 128 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 129 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 130 Rest of North America Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 131 Rest of North America Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 132 Rest of North America Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 133 Rest of North America Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 134 Rest of North America Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 135 Rest of North America Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 136 Europe Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 137 Europe Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 138 Europe Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 139 Europe Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 140 Europe Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 141 Europe Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 142 Europe Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 143 Europe Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 144 Europe Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 145 Europe Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 146 Europe Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 147 Europe Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 148 Europe Physicians Offices Market by Country, 2019 - 2022, USD Million
TABLE 149 Europe Physicians Offices Market by Country, 2023 - 2030, USD Million
TABLE 150 Europe Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
TABLE 151 Europe Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
TABLE 152 Europe Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 153 Europe Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 154 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 155 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 156 Europe Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 157 Europe Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 158 Europe RT-PCR Market by Country, 2019 - 2022, USD Million
TABLE 159 Europe RT-PCR Market by Country, 2023 - 2030, USD Million
TABLE 160 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
TABLE 161 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
TABLE 162 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 163 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 164 Europe Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 165 Europe Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 166 Europe Respiratory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 167 Europe Respiratory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 168 Europe Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
TABLE 169 Europe Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
TABLE 170 Europe Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
TABLE 171 Europe Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
TABLE 172 Europe Cancer Market by Country, 2019 - 2022, USD Million
TABLE 173 Europe Cancer Market by Country, 2023 - 2030, USD Million
TABLE 174 Europe Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 175 Europe Hepatitis Market by Country, 2023 - 2030, USD Million
TABLE 176 Europe Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
TABLE 177 Europe Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
TABLE 178 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 179 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 180 Europe Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 181 Europe Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 182 Germany Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 183 Germany Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 184 Germany Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 185 Germany Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 186 Germany Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 187 Germany Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 188 Germany Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 189 Germany Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 190 Germany Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 191 Germany Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 192 UK Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 193 UK Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 194 UK Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 195 UK Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 196 UK Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 197 UK Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 198 UK Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 199 UK Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 200 UK Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 201 UK Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 202 France Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 203 France Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 204 France Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 205 France Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 206 France Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 207 France Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 208 France Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 209 France Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 210 France Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 211 France Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 212 Russia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 213 Russia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 214 Russia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 215 Russia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 216 Russia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 217 Russia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 218 Russia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 219 Russia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 220 Russia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 221 Russia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 222 Spain Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 223 Spain Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 224 Spain Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 225 Spain Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 226 Spain Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 227 Spain Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 228 Spain Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 229 Spain Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 230 Spain Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 231 Spain Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 232 Italy Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 233 Italy Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 234 Italy Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 235 Italy Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 236 Italy Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 237 Italy Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 238 Italy Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 239 Italy Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 240 Italy Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 241 Italy Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 242 Rest of Europe Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 243 Rest of Europe Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 244 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 245 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 246 Rest of Europe Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 247 Rest of Europe Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 248 Rest of Europe Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 249 Rest of Europe Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 250 Rest of Europe Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 251 Rest of Europe Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 252 Asia Pacific Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 253 Asia Pacific Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 254 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 255 Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 256 Asia Pacific Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 257 Asia Pacific Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 258 Asia Pacific Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 259 Asia Pacific Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 260 Asia Pacific Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 261 Asia Pacific Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 262 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 263 Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 264 Asia Pacific Physicians Offices Market by Country, 2019 - 2022, USD Million
TABLE 265 Asia Pacific Physicians Offices Market by Country, 2023 - 2030, USD Million
TABLE 266 Asia Pacific Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
TABLE 267 Asia Pacific Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
TABLE 268 Asia Pacific Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 269 Asia Pacific Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 270 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 271 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 272 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 273 Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 274 Asia Pacific RT-PCR Market by Country, 2019 - 2022, USD Million
TABLE 275 Asia Pacific RT-PCR Market by Country, 2023 - 2030, USD Million
TABLE 276 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
TABLE 277 Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
TABLE 278 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 279 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 280 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 281 Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 282 Asia Pacific Respiratory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 283 Asia Pacific Respiratory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 284 Asia Pacific Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
TABLE 285 Asia Pacific Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
TABLE 286 Asia Pacific Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
TABLE 287 Asia Pacific Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
TABLE 288 Asia Pacific Cancer Market by Country, 2019 - 2022, USD Million
TABLE 289 Asia Pacific Cancer Market by Country, 2023 - 2030, USD Million
TABLE 290 Asia Pacific Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 291 Asia Pacific Hepatitis Market by Country, 2023 - 2030, USD Million
TABLE 292 Asia Pacific Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
TABLE 293 Asia Pacific Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
TABLE 294 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 295 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 296 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 297 Asia Pacific Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million

TABLE 298 China Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 299 China Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 300 China Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 301 China Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 302 China Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 303 China Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 304 China Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 305 China Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 306 China Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 307 China Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 308 Japan Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 309 Japan Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 310 Japan Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 311 Japan Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 312 Japan Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 313 Japan Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 314 Japan Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 315 Japan Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 316 Japan Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 317 Japan Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 318 India Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 319 India Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 320 India Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 321 India Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 322 India Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 323 India Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 324 India Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 325 India Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 326 India Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 327 India Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 328 South Korea Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 329 South Korea Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 330 South Korea Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 331 South Korea Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 332 South Korea Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 333 South Korea Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 334 South Korea Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 335 South Korea Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 336 South Korea Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 337 South Korea Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 338 Singapore Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 339 Singapore Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 340 Singapore Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 341 Singapore Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 342 Singapore Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 343 Singapore Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 344 Singapore Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 345 Singapore Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 346 Singapore Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 347 Singapore Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 348 Malaysia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 349 Malaysia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 350 Malaysia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 351 Malaysia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 352 Malaysia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 353 Malaysia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 354 Malaysia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 355 Malaysia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 356 Malaysia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 357 Malaysia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 358 Rest of Asia Pacific Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 359 Rest of Asia Pacific Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 360 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 361 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 362 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 363 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 364 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 365 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 366 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 367 Rest of Asia Pacific Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 368 LAMEA Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 369 LAMEA Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 370 LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 371 LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 372 LAMEA Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 373 LAMEA Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 374 LAMEA Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 375 LAMEA Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 376 LAMEA Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 377 LAMEA Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 378 LAMEA Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 379 LAMEA Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 380 LAMEA Physicians Offices Market by Country, 2019 - 2022, USD Million
TABLE 381 LAMEA Physicians Offices Market by Country, 2023 - 2030, USD Million
TABLE 382 LAMEA Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
TABLE 383 LAMEA Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
TABLE 384 LAMEA Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 385 LAMEA Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 386 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 387 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 388 LAMEA Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 389 LAMEA Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 390 LAMEA RT-PCR Market by Country, 2019 - 2022, USD Million
TABLE 391 LAMEA RT-PCR Market by Country, 2023 - 2030, USD Million
TABLE 392 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
TABLE 393 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
TABLE 394 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 395 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 396 LAMEA Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 397 LAMEA Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 398 LAMEA Respiratory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 399 LAMEA Respiratory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 400 LAMEA Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
TABLE 401 LAMEA Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
TABLE 402 LAMEA Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
TABLE 403 LAMEA Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
TABLE 404 LAMEA Cancer Market by Country, 2019 - 2022, USD Million
TABLE 405 LAMEA Cancer Market by Country, 2023 - 2030, USD Million
TABLE 406 LAMEA Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 407 LAMEA Hepatitis Market by Country, 2023 - 2030, USD Million
TABLE 408 LAMEA Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
TABLE 409 LAMEA Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
TABLE 410 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 411 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 412 LAMEA Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 413 LAMEA Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 414 Brazil Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 415 Brazil Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 416 Brazil Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 417 Brazil Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 418 Brazil Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 419 Brazil Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 420 Brazil Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 421 Brazil Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 422 Brazil Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 423 Brazil Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 424 Argentina Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 425 Argentina Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 426 Argentina Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 427 Argentina Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 428 Argentina Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 429 Argentina Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 430 Argentina Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 431 Argentina Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 432 Argentina Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 433 Argentina Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 434 UAE Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 435 UAE Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 436 UAE Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 437 UAE Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 438 UAE Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 439 UAE Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 440 UAE Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 441 UAE Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 442 UAE Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 443 UAE Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 444 Saudi Arabia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 445 Saudi Arabia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 446 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 447 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 448 Saudi Arabia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 449 Saudi Arabia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 450 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 451 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 452 Saudi Arabia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 453 Saudi Arabia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 454 South Africa Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 455 South Africa Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 456 South Africa Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 457 South Africa Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 458 South Africa Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 459 South Africa Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 460 South Africa Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 461 South Africa Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 462 South Africa Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 463 South Africa Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 464 Nigeria Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 465 Nigeria Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 466 Nigeria Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 467 Nigeria Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 468 Nigeria Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 469 Nigeria Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 470 Nigeria Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 471 Nigeria Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 472 Nigeria Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 473 Nigeria Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 474 Rest of LAMEA Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 475 Rest of LAMEA Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 476 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 477 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 478 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 479 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 480 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 481 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 482 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 483 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 484 Key Information - Abbott Laboratories
TABLE 485 Key Information - Bayer AG
TABLE 486 Key Information - Thermo Fisher Scientific, Inc.
TABLE 487 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
TABLE 488 Key information - BioMerieux S.A.
TABLE 489 Key Information - Qiagen N.V.
TABLE 490 Key Information - Danaher Corporation
TABLE 491 Key Information - Bio-Rad Laboratories, Inc.
TABLE 492 key Information - Agilent Technologies, Inc.
TABLE 493 key information - Nova Biomedical Corporation

List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Global Point of Care Molecular Diagnostics Market share by Product & Service, 2022
FIG 5 Global Point of Care Molecular Diagnostics Market share by Product & Service, 2030
FIG 6 Global Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2030, USD Million
FIG 7 Global Point of Care Molecular Diagnostics Market share by End User, 2022
FIG 8 Global Point of Care Molecular Diagnostics Market share by End User, 2030
FIG 9 Global Point of Care Molecular Diagnostics Market by End User, 2019 - 2030, USD Million
FIG 10 Global Point of Care Molecular Diagnostics Market share by Technology, 2022
FIG 11 Global Point of Care Molecular Diagnostics Market share by Technology, 2030
FIG 12 Global Point of Care Molecular Diagnostics Market by Technology, 2019 - 2030, USD Million
FIG 13 Global Point of Care Molecular Diagnostics Market share by Application, 2022
FIG 14 Global Point of Care Molecular Diagnostics Market share by Application, 2030
FIG 15 Global Point of Care Molecular Diagnostics Market by Application, 2019 - 2030, USD Million
FIG 16 Global Point of Care Molecular Diagnostics Market share by Region, 2022
FIG 17 Global Point of Care Molecular Diagnostics Market share by Region, 2030
FIG 18 Global Point of Care Molecular Diagnostics Market by Region, 2019 - 2030, USD Million
FIG 19 Swot Analysis: Abbott Laboratories
FIG 20 Swot Analysis: Bayer AG
FIG 21 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 22 Recent strategies and developments: F. Hoffmann-La Roche Ltd.